|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
McGlynn KA, Petrick JL and London WT:
Global epidemiology of hepatocellular carcinoma: An emphasis on
demographic and regional variability. Clin Liver Dis. 19:223–238.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zucman-Rossi J, Villanueva A, Nault JC and
Llovet JM: Genetic landscape and biomarkers of hepatocellular
carcinoma. Gastroenterology. 149:1226–1239.e4. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Szabo G and Bala S: MicroRNAs in liver
disease. Nat Rev Gastroenterol Hepatol. 10:542–552. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu SY, Lan SH and Liu HS: Autophagy and
microRNA in hepatitis B virus-related hepatocellular carcinoma.
World J Gastroenterol. 22:176–187. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang J and Ma L: MicroRNA control of
epithelial-mesenchymal transition and metastasis. Cancer Metastasis
Rev. 31:653–662. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
de Cedrón MG and de Molina AR:
Microtargeting cancer metabolism: Opening new therapeutic windows
based on lipid metabolism. J Lipid Res. 57:193–206. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Peschansky VJ and Wahlestedt C: Non-coding
RNAs as direct and indirect modulators of epigenetic regulation.
Epigenetics. 9:3–12. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Callegari E, Elamin BK, Sabbioni S,
Gramantieri L and Negrini M: Role of microRNAs in hepatocellular
carcinoma: A clinical perspective. Onco Targets Ther. 6:1167–1178.
2013.PubMed/NCBI
|
|
11
|
Takeyama H, Yamamoto H, Yamashita S, Wu X,
Takahashi H, Nishimura J, Haraguchi N, Miyake Y, Suzuki R, Murata
K, et al: Decreased miR-340 expression in bone marrow is associated
with liver metastasis of colorectal cancer. Mol Cancer Ther.
13:976–985. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li P, Sun Y and Liu Q: MicroRNA-340
induces apoptosis and inhibits metastasis of ovarian cancer cells
by inactivation of NF-x03BA;B1. Cell Physiol Biochem. 38:1915–1927.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mohammadi-Yeganeh S, Paryan M, Arefian E,
Vasei M, Ghanbarian H, Mahdian R, Karimipoor M and Soleimani M:
MicroRNA-340 inhibits the migration, invasion, and metastasis of
breast cancer cells by targeting Wnt pathway. Tumour Biol.
37:8993–9000. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fernandez S, Risolino M, Mandia N, Talotta
F, Soini Y, Incoronato M, Condorelli G, Banfi S and Verde P:
miR-340 inhibits tumor cell proliferation and induces apoptosis by
targeting multiple negative regulators of p27 in non-small cell
lung cancer. Oncogene. 34:3240–3250. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sun Y, Zhao X, Zhou Y and Hu Y: miR-124,
miR-137 and miR-340 regulate colorectal cancer growth via
inhibition of the Warburg effect. Oncol Rep. 28:1346–1352. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu P, Li Y, Zhang H, Li M and Zhu H:
MicroRNA-340 mediates metabolic shift in oral squamous cell
carcinoma by targeting glucose transporter-1. J Oral Maxillofac
Surg. 74:844–850. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Negrini M, Ferracin M, Sabbioni S and
Croce CM: MicroRNAs in human cancer: From research to therapy. J
Cell Sci. 120:1833–1840. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang X, Liu S, Hu T, Liu S, He Y and Sun
S: Up-regulated microRNA-143 transcribed by nuclear factor kappa B
enhances hepatocarcinoma metastasis by repressing fibronectin
expression. Hepatology. 50:490–499. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee SW, Li CF, Jin G, Cai Z, Han F, Chan
CH, Yang WL, Li BK, Rezaeian AH, Li HY, et al: Skp2-dependent
ubiquitination and activation of LKB1 is essential for cancer cell
survival under energy stress. Mol Cell. 57:1022–1033. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cai H, Lin L, Cai H, Tang M and Wang Z:
Combined microRNA-340 and ROCK1 mRNA profiling predicts tumor
progression and prognosis in pediatric osteosarcoma. Int J Mol Sci.
15:560–573. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang D, Qiu S, Ge R, He L, Li M, Li Y and
Peng Y: miR-340 suppresses glioblastoma multiforme. Oncotarget.
6:9257–9270. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Strong AM Poenitzsch, Setaluri V and
Spiegelman VS: MicroRNA-340 as a modulator of RAS-RAF-MAPK
signaling in melanoma. Arch Biochem Biophys. 563:118–124. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huang K, Tang Y, He L and Dai Y:
MicroRNA-340 inhibits prostate cancer cell proliferation and
metastasis by targeting the MDM2-p53 pathway. Oncol Rep.
35:887–895. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wei P, Qiao B, Li Q, Han X, Zhang H, Huo Q
and Sun J: microRNA-340 suppresses tumorigenic potential of
prostate cancer cells by targeting high-mobility group
nucleosome-binding domain 5. DNA Cell Biol. 35:33–43. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yu W, Zhang G, Lu B, Li J, Wu Z, Ma H,
Wang H and Lian R: MiR-340 impedes the progression of laryngeal
squamous cell carcinoma by targeting EZH2. Gene. 577:193–201. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hou LK, Yu Y, Xie YG, Wang J, Mao JF,
Zhang B, Wang X and Cao XC: miR-340 and ZEB1 negative feedback loop
regulates TGF-β- mediated breast cancer progression. Oncotarget.
7:26016–26026. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huang X, Wu Z, Mei Y and Wu M: XIAP
inhibits autophagy via XIAP-Mdm2-p53 signalling. EMBO J.
32:2204–2216. 2013. View Article : Google Scholar : PubMed/NCBI
|
